NGEN

Nervgen Pharma CORP

+$6.4M

Net Activity

Institutions Holding

45

Popularity Rank

#6255

Avg Weight

0.00%

Total Value

$6.4M

Ownership Trend

45 institutions currently hold NGEN, with 44 net buyers and 0 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

0

Net Buying Institutions

44

Key Holders

View all 45 holding institutions

Quarterly Activity

Recent Activity

+$6.4M

Total Buy Value

$0.0

Total Sell Value

New buy44
Trim0
Add0
Sold out0

44

Net Buyers

0

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding NERVGEN PHARMA CORP (NGEN)?
Major stakeholders currently include PFG Investments, LLC ($757.8K), Bank Of America CORP /de/ ($756.5K), Marshall Wace, LLP ($755.4K). Based on the latest 13F filings, there are a total of 45 tracked investment funds and institutions maintaining positions in NGEN.
What is the overall institutional sentiment toward NGEN recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $6.4M, driven by 44 managers accumulating shares while 0 reduced their exposure.
Which institutions have been selling or reducing their NGEN positions?
In the latest period, no tracked funds trimmed or exited their positions in NGEN.
Are there any notable investors adding NGEN to their portfolios?
Yes, buying activity remains notable. 44 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $6.4M.

Related Stocks